Selected research
Industry Research
Gene Overexpression Cell Line Construction Service Industry Research Report 2026
Market perspective
The global Gene Overexpression Cell Line Construction Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Overexpression Cell Line Construction Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Overexpression Cell Line Construction Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Overexpression Cell Line Construction Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Overexpression Cell Line Construction Service include Jiangyuan Biotechnology, Yuanjing Biology, OBiO Technology, VectorBuilder, Boyuan Group, Horizon Discovery, Creative Biogene, ACROBiosystems and Creative Bioarray, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Overexpression Cell Line Construction Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Overexpression Cell Line Construction Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Overexpression Cell Line Construction Service Market by Company
Jiangyuan Biotechnology
Yuanjing Biology
OBiO Technology
VectorBuilder
Boyuan Group
Horizon Discovery
Creative Biogene
ACROBiosystems
Creative Bioarray
CUSABIO
SBI
Cyagen
Sino Biological
Gene Overexpression Cell Line Construction Service Segment by Type
Transient Overexpression
Stable Overexpression
Gene Overexpression Cell Line Construction Service Segment by Application
Biomedicine
Functional Genomics
Protein Engineering
Other
Gene Overexpression Cell Line Construction Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Overexpression Cell Line Construction Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Overexpression Cell Line Construction Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Overexpression Cell Line Construction Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Overexpression Cell Line Construction Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transient Overexpression
- Stable Overexpression
Applications
- Biomedicine
- Functional Genomics
- Protein Engineering
- Other
Companies covered
- Jiangyuan Biotechnology
- Yuanjing Biology
- OBiO Technology
- VectorBuilder
- Boyuan Group
- Horizon Discovery
- Creative Biogene
- ACROBiosystems
- Creative Bioarray
- CUSABIO
- SBI
- Cyagen
- Sino Biological
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Overexpression Cell Line Construction Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Transient Overexpression
- 2.2.3 Stable Overexpression
- 2.3 Gene Overexpression Cell Line Construction Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedicine
- 2.3.3 Functional Genomics
- 2.3.4 Protein Engineering
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Gene Overexpression Cell Line Construction Service Breakdown Data by Type
- 3.1 Global Gene Overexpression Cell Line Construction Service Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Overexpression Cell Line Construction Service Forecasted Market Size by Type (2027-2032)
4 Gene Overexpression Cell Line Construction Service Breakdown Data by Application
- 4.1 Global Gene Overexpression Cell Line Construction Service Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Overexpression Cell Line Construction Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Overexpression Cell Line Construction Service Market Perspective (2021-2032)
- 5.2 Global Gene Overexpression Cell Line Construction Service Growth Trends by Region
- 5.2.1 Global Gene Overexpression Cell Line Construction Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Overexpression Cell Line Construction Service Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Overexpression Cell Line Construction Service Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Overexpression Cell Line Construction Service Market Dynamics
- 5.3.1 Gene Overexpression Cell Line Construction Service Industry Trends
- 5.3.2 Gene Overexpression Cell Line Construction Service Market Drivers
- 5.3.3 Gene Overexpression Cell Line Construction Service Market Challenges
- 5.3.4 Gene Overexpression Cell Line Construction Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Overexpression Cell Line Construction Service Players by Revenue
- 6.1.1 Global Top Gene Overexpression Cell Line Construction Service Players by Revenue (2021-2026)
- 6.1.2 Global Gene Overexpression Cell Line Construction Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Overexpression Cell Line Construction Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Overexpression Cell Line Construction Service Head Office and Area Served
- 6.4 Global Gene Overexpression Cell Line Construction Service Players, Product Type & Application
- 6.5 Global Gene Overexpression Cell Line Construction Service Manufacturers Established Date
- 6.6 Global Gene Overexpression Cell Line Construction Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Overexpression Cell Line Construction Service Market Size (2021-2032)
- 7.2 North America Gene Overexpression Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Overexpression Cell Line Construction Service Market Size by Country (2021-2026)
- 7.4 North America Gene Overexpression Cell Line Construction Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Overexpression Cell Line Construction Service Market Size (2021-2032)
- 8.2 Europe Gene Overexpression Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Overexpression Cell Line Construction Service Market Size by Country (2021-2026)
- 8.4 Europe Gene Overexpression Cell Line Construction Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Overexpression Cell Line Construction Service Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Overexpression Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Overexpression Cell Line Construction Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Overexpression Cell Line Construction Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Overexpression Cell Line Construction Service Market Size (2021-2032)
- 10.2 South America Gene Overexpression Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Overexpression Cell Line Construction Service Market Size by Country (2021-2026)
- 10.4 South America Gene Overexpression Cell Line Construction Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Overexpression Cell Line Construction Service Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Overexpression Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Overexpression Cell Line Construction Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Overexpression Cell Line Construction Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Jiangyuan Biotechnology
- 12.1.1 Jiangyuan Biotechnology Company Information
- 12.1.2 Jiangyuan Biotechnology Business Overview
- 12.1.3 Jiangyuan Biotechnology Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.1.4 Jiangyuan Biotechnology Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.1.5 Jiangyuan Biotechnology Recent Developments
- 12.2 Yuanjing Biology
- 12.2.1 Yuanjing Biology Company Information
- 12.2.2 Yuanjing Biology Business Overview
- 12.2.3 Yuanjing Biology Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.2.4 Yuanjing Biology Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.2.5 Yuanjing Biology Recent Developments
- 12.3 OBiO Technology
- 12.3.1 OBiO Technology Company Information
- 12.3.2 OBiO Technology Business Overview
- 12.3.3 OBiO Technology Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.3.4 OBiO Technology Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.3.5 OBiO Technology Recent Developments
- 12.4 VectorBuilder
- 12.4.1 VectorBuilder Company Information
- 12.4.2 VectorBuilder Business Overview
- 12.4.3 VectorBuilder Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.4.4 VectorBuilder Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.4.5 VectorBuilder Recent Developments
- 12.5 Boyuan Group
- 12.5.1 Boyuan Group Company Information
- 12.5.2 Boyuan Group Business Overview
- 12.5.3 Boyuan Group Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.5.4 Boyuan Group Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.5.5 Boyuan Group Recent Developments
- 12.6 Horizon Discovery
- 12.6.1 Horizon Discovery Company Information
- 12.6.2 Horizon Discovery Business Overview
- 12.6.3 Horizon Discovery Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.6.4 Horizon Discovery Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.6.5 Horizon Discovery Recent Developments
- 12.7 Creative Biogene
- 12.7.1 Creative Biogene Company Information
- 12.7.2 Creative Biogene Business Overview
- 12.7.3 Creative Biogene Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.7.4 Creative Biogene Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.7.5 Creative Biogene Recent Developments
- 12.8 ACROBiosystems
- 12.8.1 ACROBiosystems Company Information
- 12.8.2 ACROBiosystems Business Overview
- 12.8.3 ACROBiosystems Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.8.4 ACROBiosystems Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.8.5 ACROBiosystems Recent Developments
- 12.9 Creative Bioarray
- 12.9.1 Creative Bioarray Company Information
- 12.9.2 Creative Bioarray Business Overview
- 12.9.3 Creative Bioarray Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.9.4 Creative Bioarray Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.9.5 Creative Bioarray Recent Developments
- 12.10 CUSABIO
- 12.10.1 CUSABIO Company Information
- 12.10.2 CUSABIO Business Overview
- 12.10.3 CUSABIO Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.10.4 CUSABIO Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.10.5 CUSABIO Recent Developments
- 12.11 SBI
- 12.11.1 SBI Company Information
- 12.11.2 SBI Business Overview
- 12.11.3 SBI Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.11.4 SBI Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.11.5 SBI Recent Developments
- 12.12 Cyagen
- 12.12.1 Cyagen Company Information
- 12.12.2 Cyagen Business Overview
- 12.12.3 Cyagen Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.12.4 Cyagen Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.12.5 Cyagen Recent Developments
- 12.13 Sino Biological
- 12.13.1 Sino Biological Company Information
- 12.13.2 Sino Biological Business Overview
- 12.13.3 Sino Biological Revenue in Gene Overexpression Cell Line Construction Service Business (2021-2026)
- 12.13.4 Sino Biological Gene Overexpression Cell Line Construction Service Product Portfolio
- 12.13.5 Sino Biological Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst